Multiple endocrine neoplasia type 1 (MEN1), an inherited tumor syndrome affecting endocrine organs including pancreatic islets, results from mutation of the tumor suppressor gene Men1 that encodes protein menin. Although menin is known to be involved in regulating cell proliferation in vitro, it is not clear how menin regulates cell cycle and whether mutation of Men1 acutely promotes pancreatic islet cell proliferation in vivo. Here we show that excision of the floxed Men1 in mouse embryonic fibroblasts (MEF) accelerates G 0 /G 1 to S phase entry. This accelerated S-phase entry is accompanied by increased cyclin-dependent kinase 2 (CDK2) activity as well as decreased expression of CDK inhibitors p18
Introduction
Multiple endocrine neoplasia type 1 (MEN1) is a dominantly inherited tumor syndrome that results from the mutation of the tumor suppressor gene Men1, which encodes menin (1, 2) . Menin interacts with multiple proteins that play critical roles in the regulation of cell proliferation, including JunD (3), Smad 3 (4), and activator of S-phase kinase (5) . Activator of S-phase kinase is the crucial regulatory factor for protein kinase cdc7 that is required for initiation of DNA replication (6, 7) and menin functionally represses the activity of activator of S-phase kinase (5) . In addition, menin interacts with a protein complex containing the mixed lineage leukemia protein (8, 9) and up-regulates transcription of various target genes, including the cyclin-dependent kinase (CDK) inhibitors p27
Kip1 and p18 Ink4c , in transformed fibroblasts (10) and insulinoma cells (11) . Whereas these observations provide a potential mechanistic link between menin and cell cycle regulation, a direct link between menin function and cell cycle progression has not been established. An obstacle to answering this question has been the lack of synchronizable cells in which Men1 can be conditionally inactivated in vitro so that the effect of Men1 deletion on the cell cycle progression can be examined.
Mouse models have greatly increased our understanding of molecular pathology of the MEN1 syndrome. Tumors derived from mice heterozygous for Men1 display loss of heterozygosity (12, 13) , confirming the role of menin as a bona fide tumor suppressor. Tumors arise in the parathyroid (14) , pituitary (15) , and pancreatic islet cells (15) (16) (17) from the mice in which Men1 is conditionally inactivated in these respective organs, establishing an important role for menin in suppressing tumor development in endocrine organs. However, because the excision of Men1 is not under temporal control in these mice, it is challenging to study the acute effects of deletion of Men1 on proliferation of pancreatic islet cells. Thus, although tumor cells in insulinomas of the mice display enhanced cell proliferation as shown by 5 ¶-bromo-2 ¶-deoxyuridine-5 ¶-triphosphate (BrdUrd) uptake (17) , it is difficult to determine how soon after Men1 deletion increased islet cell proliferation occurs. If increased islet proliferation is an acute consequence of Men1 deletion, then this would suggest that loss of menin-mediated repression of cell proliferation is at least in part responsible for the early events of MEN1 tumorigenesis. A mouse model in which Men1 can be deleted in a temporally controllable manner will help to address this question. Answering this question is important for identifying the pathways through which menin controls tumorigenesis in endocrine organs and for understanding how to potentially manipulate these pathways for therapeutic intervention.
In the current studies, mouse embryonic fibroblasts (MEF) in which Men1 could be conditionally deleted were generated. Unlike viral oncogene-immortalized Men1 À/À MEFs (18) , these MEFs could be synchronized to determine the effect of menin on cell cycle progression. In addition, we established a model system in which the floxed Men1 locus could be excised in a temporally controlled fashion so that the acute effect of in vivo Men1 excision on cell proliferation could be examined. These technical advances allowed us to establish a crucial role for menin in repressing cell cycle entry into S phase in vitro as well as in suppressing proliferation of normal pancreatic islet cells in vivo.
Resources, the University of Pennsylvania committee on animal care, and were carried out in accordance with the mandated standards. Men1 ;Cre-ER mice at 12 weeks of age were first fed with tamoxifen (Sigma, St. Louis, MO) at a dose of 200 mg/kg body weight/d for 2 consecutive days, followed by a day off and then for a second 2 consecutive days at the same dose. After 7, 14, and 30 days, the mice were sacrificed for analysis. In total, 22 mice (11 male and 11 female) were analyzed, with the male and female mice randomly distributed between the two groups.
Immunofluorescent staining of pancreatic sections. Men1 l/l ;Cre-ER and control Men1 +/+ ;Cre-ER mice (both tamoxifen-fed) were injected i.p. with 50 mg BrdUrd (Sigma)/kg body weight 2 hours before sacrifice and dissection. Pancreata were isolated and processed for H&E staining and three separate sections from each mouse were stained to quantify area of islets using Metamorph software (Molecular Devices Corporation, Sunnyvale, CA). For immunofluorescent staining, a rabbit antimenin antibody (#80; ref. 18 ) and a sheep anti-BrdUrd antibody (#2284, Abcam, Inc., Cambridge, United Kingdom) were used in combination with FITCconjugated antirabbit IgG and TRITC-conjugated antisheep IgG secondary antibodies, together with 4 ¶,6-diamidino-2-phenylindole (DAPI; 10 Ag/mL). Images were captured under a Nikon eclipse E800 fluorescent microscope equipped with a CCD digital camera and the BrdUrd-positive cells among the total DAPI-stained cells per islet were quantified. To costain BrdUrd with insulin or glucagon in islet cells, the following antibodies were used: monoclonal rat anti-BrdUrd (BU1/75-ICR1, Accurate Chemical & Scientfic Corp., Westbury, NY), Cy2-conjugated antirat IgG, guinea pig anti-insulin, rabbit antiglucagon (Abcam), FITC-conjugated goat anti-rabbit IgG (Molecular Probes, Inc., Eugene, OR), and FITC-conjugated goat anti-guinea pig IgG (Abcam).
RT-PCR and real-time TaqMan PCR. Total RNA was extracted from cell lines and pancreata using the RNeasy Mini Kit (Qiagen, Valencia, CA). Onestep RT-PCR was done with RNA derived from pancreata using the Titan One Tube RT-PCR System (Roche, Indianapolis, IN) following the instructions of the manufacturer. Real-time TaqMan PCR quantification of gene expression was done with RNA derived from cultured cell lines using TaqMan probes for p18
Ink4c (Applied Biosystems, Foster City, CA; Mm00483243_m1), p27 Kip1 (Mm00438167_g1), and GAPDH as an internal control (Mm99999915_g1). Analysis was done using the relative quantification method according to instructions from the ABI. Plasmid construction and production of recombinant viruses. Plasmids for generating recombinant retroviruses were constructed by inserting PCR-amplified human menin cDNA into the BamHI/NotI site of the retroviral vector pMX-puro to generate pMX-menin. The production of recombinant adenoviruses and retroviruses was as previously described (22) . For complementation with wild-type menin, Men1 D/D 1 cells were seeded on day 0, infected with various retroviruses [including green fluorescent protein (GFP)-expressing retroviruses as a control for infection efficiency] on day 1, and switched to fresh media on day 2 before selection with 2 Ag/mL puromycin on day 4.
Generation of MEF cell lines and fluorescence-activated cell sorting analysis. MEFs from Men1 l/l embryos were isolated on embryonic day 14 (E14) and were immortalized using the 3T9 protocol (23 2). After two to three passages of Men1 excision, the cells were seeded in MEF medium (22) at a density of 1.5 Â 10 5 per 100-mm dish on day 0 for cell cycle analysis. On day 1, cells were switched to medium containing only 0.1% FBS. On day 5, normal MEF medium containing nocodazole (Sigma; 200 ng/mL) was added to cells, releasing them from arrest in G 0 /G 1 . At various time points after release, cells were pulsed with 10 Amol/L BrdUrd for 2 hours immediately before harvest and fixation. Cell pellets were processed for double staining with an anti-BrdUrd antibody (PharMingen, San Jose, CA) and propidium iodide (10 Ag/mL in PBS; Sigma), followed by analysis on a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ). Gating was done to focus on the G 1 , S, and G 2 -M populations.
Antibodies and Western blotting. Whole-cell lysates were prepared with ELB lysis buffer [0.1% NP40, 160 mmol/L NaCl, 50 mmol/L HEPES (pH 7.4), 5 mmol/L EDTA (pH 8.0), 1 mmol/L DTT, 0.2 mmol/L phenylmethylsulfonyl fluoride; ref. 24] supplemented with protease inhibitor cocktail set (Calbiochem, San Diego, CA) and subjected to Western blotting analysis as previously described (22) . The primary antibodies used were rabbit antimenin (BL-342, Bethyl Lab, Montgomery, TX), goat antiactin (C-11, Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-p27 Kip1 (BD Transduction, San Jose, CA), rabbit anti-p18 (N-20), rabbit anti-p21 (C-19), and rabbit anti-p16 (M-156; Santa Cruz Biotechnology).
CDK kinase assays. Cells were lysed in ELB lysis buffer and the lysates (250 Ag) were immunoprecipitated by 5 Ag of antimouse CDK2 antibody (Santa Cruz Biotechnology) or control rabbit IgG. Immunoprecipitates were incubated with 2 Ag histone H1 (Upstate Biotech, Norcross, GA) and 5 ACi [g-32 P]ATP for 30 minutes before SDS-PAGE separation, as previously described (25) , and subjected to phosphoimaging analysis and quantification. Total histone substrate was visualized by Coomassie blue staining.
Statistical analysis and quantification. Microsoft Excel and GraphPad Prism software were used to prepare graphs and for statistical analyses. When appropriate, the Student's t test was used to determine significance of results.
Results
Ablation of Men1 in vitro increases cell proliferation and transition from G 0 /G 1 to S phase. We immortalized MEFs from mouse embryos with the floxed Men1 (17) using the 3T9 protocol (23) , and then infected the cells with recombinant adenoviruses expressing either GFP (Ad-GFP) or Cre (Ad-Cre) that could excise the floxed Men1 from the genome. The cell lysates from the infected cells were subjected to Western blotting analysis. Ad-Cre (lanes 2 and 3), but not Ad-GFP (lane 1), abrogated expression of menin (Fig. 1A) . Men1 excision was also confirmed by genotyping ( To further confirm this difference in cell proliferation in vitro, we excised Men1 1/l from one additional independent clone and similar results were obtained. 2 We next determined whether menin inhibits cell cycle progression and, if it does, at what phase it inhibits cell cycle progression. Serum-starved menin-null or menin-expressing cells were stimulated by addition of serum and allowed to progress for various periods of time up to 24 hours. Cells were harvested at various time points after release and processed for staining with anti-BrdUrd antibody and propidium iodide, followed by flow cytometry analysis. Following serum removal, Men1 l/l cells were distributed at G 0 /G 1 (48%) and G 2 -M (48.1%), with only 3.9% of the cells in S phase ( Fig Ablation of Men1 increases CDK2 activity, but decreases p18
Ink4c and p27 Kip1 RNA and protein levels. The cell cycle is positively regulated by various CDKs and CDK2 plays a crucial role in controlling G 0 /G 1 to S transition (26) . Thus, we determined whether menin inhibits CDK2 activity. Lysates from Men1 l/l cells and Men1 D/D 1 cells, at various time points of cell cycle progression,
were immunoprecipitated with an anti-CDK2 antibody, and the precipitated kinase activity was detected using histone H1 as a substrate. Figure 3A (top) shows that CDK2 activity, as indicated by the amount of phosphorylation of histone H1, increased after Men1 was excised (lanes 5-7). Quantification of phosphorylation shows that the CDK2 activity was f2-fold higher in Men1 D/D 1 cells than in Men1 l/l cells at each corresponding time point (Fig. 3A, bottom) . Menin expression did not alter the phosphorylation of the inhibitory Y15 residue nor the activating T160 residue of CDK2. 3 This result suggests that loss of menin expression increases the CDK2 activity and promotes G 0 /G 1 to S transition.
Because the CDK inhibitors p18 Ink4c and p27 Kip1 are implicated in menin-mediated repression of cell proliferation in transformed MEFs (10) (Fig. 3B ). In addition, the mRNA levels of p27
Kip1
and p18 Ink4c in Men1 l/l cells are 2.5-fold (P < 0.02) and 3.5-fold (P < 0.001) higher, respectively, than in Men1 D/D 1 cells (Fig. 3C ).
Although menin-dependent transcription of p27 Kip1 and p18
Ink4c
was recently reported (10), this is the first time that menin was shown to suppress cell cycle progression, repress CDK2 activity, and up-regulate p27 Kip1 and p18 Ink4c in a well-controlled system. These data suggest that menin regulates CDK2, at least in part, by regulating p27 Kip1 (Fig. 4A) ; these differences were significant (P < 0.0006). In addition, expression of p27 Kip1 and p18 Ink4c was higher in menin-complemented cells than in vector-complemented cells at both the protein and mRNA (Fig. 4B and C) levels, consistent with a previous report (10) that menin is crucial for optimal expression of p27 Kip1 (P < 0.003) and p18 Ink4c (P < 0.0002). To further confirm the crucial role of menin in regulating cell cycle progression, we tested if complementing cells with menin can rescue the role of menin in suppressing transition from G 0 /G 1 to S phase. Following serum starvation, 12.5% of vector-complemented cells and 10% of menin-complemented cells were in S phase (Fig. 4D) . 
Notably, 12 hours after release, 33% of vector-complemented cells were in S phase, as compared with 16% in menin-complemented cells (Fig. 4D) . Twenty-four hours after release, vector-complemented cells progressed out of the peak of S phase (31%) whereas a greater percentage of menin-complemented cells remained in S phase (36%; Fig. 4D) . A more detailed cell cycle profile at multiple time points after G 0/1 release further supports the role of menin in slowing down G 0 to S phase transition (Fig. 4E) . Ink4c and p27 Kip1 protein levels. The indicated cells were released from serum starvation and harvested at the indicated time points, and then subjected for Western blotting with the indicated antibodies. C, ablation of Men1 decreases p18
Ink4c and p27 Kip1 RNA levels. Real-time TaqMan PCR analysis was carried out using TaqMan probes for p18
Ink4c , p27 Kip1 , and GAPDH. D, the p27 Kip1 and p18 Ink4c mRNA levels decrease in Men1 excision in pancreatic islets acutely results in increased islet cell proliferation and size. The above studies in cultured cells showed a crucial role for menin in controlling S-phase entry. However, it is still unclear whether this role of menin also applies to in vivo endocrine cells such as pancreatic islet cells, in which a germ-line mutation in only one Men1 allele predisposes the patient to the development of insulinomas (28) . In addition, because it takes f6 months for mice carrying a Men1 mutation to develop insulinomas, which have a high proliferation index (17) , an important unresolved question is whether time-controlled Men1 excision can quickly lead to enhanced proliferation of pancreatic islet cells. To address these questions, we bred mice with the Men1 locus flanked by lox P sites (Men1 l/l , previously Men1 DN/DN ; ref. 17) with mice (Men1 +/+ ) expressing Cre-ER (estrogen receptor) driven by a pan-active UBC9 promoter, 1 to generate mice with the Men1 l/l ; Cre-ER genotype. Cre-ER expressed from a transgene can be activated by tamoxifen, resulting in excision of genes flanked by lox P sites (29) . Both control mice (Men1 +/+ ) expressing Cre-ER and the Men1 l/l ;Cre-ER mice were fed with tamoxifen, and then pancreata were harvested to determine excision of the conditional Men1 locus. Tamoxifen effectively induced Men1 excision in the pancreata of the Men1 l/l ;Cre-ER mice ( Fig. 5A and B, lane 2), but not in Men +/+ ;Cre-ER mice (Fig. 5B, lane 1) . Conversely, in the absence of tamoxifen, the floxed Men1 remained intact in the pancreata of Men1 l/l ;Cre-ER mice, indicating no leakiness in excision of the Men1 locus in the absence of tamoxifen (Fig. 5B, lane 3) . Given the effective control of Men1 excision, further experiments were done using Men1 +/+ ;Cre-ER and Men1 l/l ;Cre-ER mice to control for any nonspecific effects of tamoxifen treatment.
To detect islet cell proliferation after Men1 excision, BrdUrd was injected into Men1 +/+ ;Cre-ER and Men1 l/l ;Cre-ER mice 1 month after the tamoxifen treatment. Pancreata from the mice were processed for staining with antimenin and anti-BrdUrd antibodies to determine the relationship between Men1 excision and BrdUrd uptake by pancreatic islet cells. Islet cells from the Men1 +/+ ;Cre-ER mice expressed menin (Fig. 5C ) but contained only one BrdUrdpositive cell (Fig. 5D and F) . In addition, menin seemed to be expressed preferentially in islet cells as compared with the adjacent exocrine cells (Fig. 5C ). In contrast, islet cells from Men1 l/l ;Cre-ER mice largely lost menin expression but contained 1 cells were complemented with vector control retroviruses or retroviruses expressing menin. The resulting cell lines were seeded in triplicate on day 0 and counted on day 4 as described in Fig. 1C . This is representative of two independent experiments. B, Western blotting analysis of cell lines indicates that complementation with menin results in increased p27
Kip1 and p18 Ink4c protein levels. C, complementation with menin results in increased p27
Kip1 and p18 Ink4c RNA levels. Real-time TaqMan PCR analysis was carried out using TaqMan probes for p18
Ink4c , p27 Kip1 , and GAPDH. D, complementation with retroviruses expressing menin represses transition from G 0 /G 1 to S phase. As in Fig. 2A , serum-starved cells were released for various periods of time to monitor cell cycle progression. E, cell cycle profiles were determined at multiple time points as indicated, as described in Fig. 2 . (Fig. 5G, H, and J) . Quantification of the BrdUrd-positive cells from islets of multiple mice indicates that f0.4% of islet cells were BrdUrd positive in Men1 +/+ ;Cre-ER mice, but notably 2.0% of cells were BrdUrd positive in Men1 l/l ;Cre-ER mice ( Fig. 5H and K; P < 0.008). To determine whether the BrdUrdpositive cells are either insulin-secreting h-cells or glucagonsecreting a-cells, pancreatic sections were costained with the anti-insulin antibody or the antiglucagon antibody. In the islet from tamoxifen-fed Men1 l/l ;Cre-ER mice, there were two BrdUrd-positive cells, both costained with the anti-insulin antibody (red in the nucleus, Fig. 5N ). Conversely, BrdUrd-positive cells were not costained with the antiglucagon antibody (Fig. 5O) . Together, these results indicate that Men1 excision leads to increased proliferation of islet cells well before the development of insulinomas. These results further support the in vitro results that menin represses G 0 /G 1 progression or S-phase entry of cultured cells (Fig. 2) .
To extend our in vitro findings about the role of menin in upregulating p27 Kip1 and p18 Ink4c to the in vivo organ such as pancreatic islets, we also determined whether loss of Men1 affects p27
Kip1 and p18 Ink4c expression in the murine pancreata. Pancreata were harvested from Men1 +/+ ;Cre-ER and Men1 l/l ;Cre-ER mice that were fed with tamoxifen. Quantification of various mRNAs from the pancreata by RT-PCR shows that Men1 expression was detectable in Men1 +/+ ;Cre-ER mice (Fig. 3D , top, lane 1) but greatly reduced in Men1 l/l ;Cre-ER mice (lanes 2 and 3) . Similarly, expression of p27
Kip1
and p18 Ink4c was also markedly decreased in Men1 l/l ;Cre-ER mice, as compared with the control mice, whereas expression of control GAPDH was comparable between Men1 +/+ ;Cre-ER and Men1 l/l ;Cre-ER mice (Fig. 3D) . These data show that menin may also regulate p27 Kip1 and p18 Ink4c levels in vivo. Enhanced islet cell proliferation after Men1 excision may affect the size of the islets after certain period of enhanced proliferation. Notably, the size of islets from Men1 l/l ;Cre-ER mice was, on average, larger than that of the control mice 1 month after tamoxifen treatment (Fig. 6A) . The mean of the area of the islets from the Men l/l ;Cre-ER mice was f3.5-fold larger than that from the control mice (Fig. 6B, 0 .50 versus 1.73, P < 0.0001). Collectively, these results indicate that deletion of Men1, within a month, leads to enhanced cell proliferation and enlargement of pancreatic islets, a tissue commonly affected in MEN1 syndrome.
To further determine how soon after Men1 deletion BrdUrd uptake increases in islet cells, we further examined pancreata at 7 and 14 days following tamoxifen treatment. At 7 days, f0.2% of islet cells in ;Cre-ER mice on day 7. However, on day 14, the mean of the area of the islets from the Men l/l ;Cre-ER mice was f1.5-fold larger than that from the control mice (Fig. 7B, 0 .84 versus 1.22, P < 0.005). These results strongly suggest that deletion of Men1 acutely results in increased cell proliferation, which may accelerate the accumulation of islet cells, resulting in islet enlargement and hyperplasia 14 days after Men1 excision.
Discussion
To understand how Men1 mutations result in MEN1 syndrome, it is important to elucidate how menin regulates cell cycle progression, proliferation of pancreatic islet cells, and the acute effect of Men1 deletion on islet cell proliferation. In this study, we initially examined the role of menin in regulating cell cycle progression in vitro and then extended the study to the proliferation of pancreatic islet cells in vivo. Using MEFs with homozygous conditional Men1 alleles, we showed that Men1 excision accelerated S-phase entry for 4 to 5 hours, the first direct evidence linking menin to inhibition of cell cycle progression. Accelerated S-phase entry in Men1-excised cells was accompanied by decrease of p18
Ink4c and p27 Kip1 in protein levels (Fig. 3B) . This is consistent with a recent report that expression of p18
Ink4c and p27
Kip1 is decreased in mouse MEN1 insulinomas as well as in an insulinoma cell line expressing low level of menin (11) .
CDK2 plays an important role in G 1 to S transition (26) and p18
Ink4c and p27 Kip1 can either directly or indirectly inhibit CDK2 (27) . Consistent with this, we found that Men1 excision led to elevated CDK2 activity, concomitant with down-regulation p18 Ink4c and p27
Kip1 and earlier entry to S phase in MEFs. To our knowledge, this is the first time that loss of menin expression is simultaneously linked to down-regulation of p18
Kip1
, increased CDK2 activity, and accelerated S-phase entry. Although it is attractive to hypothesize that increased CDK2 activity in menin-null cells contributes to the accelerated S-phase entry, the increased CDK2 activity may not directly cause the accelerated S-phase entry. Our findings that menin-mediated expression of p18
correlates with the delayed entry to S phase are also in agreement with the report that double mutation of p18 Ink4c and p27
enhances transition from G 0 to S phase in muscle cells (30) . However, our findings do no necessarily mean that p18 Ink4c and p27
Kip1 are the major effectors of menin-mediated inhibition of G 0 to S phase transition. It is possible that the potential effect of Men1 excision on cell cycle withdrawal and maintenance of quiescence ;Cre-ER mice as described in Materials and Methods. Circles, value of the area for a single islet in arbitrary units. Line, mean of areas of all the measured islets. ;Cre-ER mice for day 7; four Men1 +/+ ; Cre-ER and four Men1 l/l ;Cre-ER mice for day 14) were processed for BrdUrd staining as described in Fig. 6C to J ;Cre-ER mice for day 14) was done as described in Fig. 6B . also in part contributes to the quicker transition to S phase. In addition, we previously also showed that menin interacted with and functionally inhibited activator of S-phase kinase, an essential component of protein kinase complex cdc7/activator of S-phase kinase that is required for S-phase entry (7) . Thus, the menin and activator of S-phase kinase interaction may also contribute to repression of entry to S-phase.
To extend our findings on the role of menin in repressing cell proliferation and S-phase entry to pancreatic islets in vivo, we determined whether deletion of Men1 quickly results in increased islet cell proliferation. Within 7 days of Men1 excision, pancreatic islet cells displayed increased BrdUrd uptake, a reliable indicator of entry into S phase. Consistent with the crucial role of menin in keeping proliferation of islet cells in check, the mean islet size gradually increased from day 14 to day 30 after Men1 excision. These results establish for the first time that loss of menin expression acutely results in enhanced cell proliferation in islet cells, a tissue commonly affected in the MEN1 patient. Thus, these results indicate that menin normally represses proliferation of islet cells, and an acute and early effect of the Men1 mutation is enhanced proliferation of islet cells including h-cells. However, these results do not exclude the possibility that secondary effects, such as defects in genome instability and apoptosis, following Men1 mutation, also contribute to MEN1 tumorigenesis.
An important related observation is that excision of Men1 accelerated proliferation of islet cells, but not the adjacent exocrine cells, indicating a tissue-specific role for menin in regulating proliferation of the endocrine pancreata. The floxed Men1 was effectively excised in the pancreas including both the exocrine and endocrine cells, based on analysis of the genomic DNA for the floxed Men1 (Fig. 5B) . The floxed Men1 locus was also effectively excised from other tissues such as bone marrow and the mouse tail (data not shown). This is consistent with the expected broad expression of the Cre-ER transgene. These results are also in accordance with a recent study showing that inactivation of Men1 in the liver, a tissue not affected in MEN1 syndrome, does not result in tumorigenesis (31) . Thus, menin may play an especially critical role in suppressing cell proliferation in endocrine organs. It is not clear how menin specifically represses the proliferation of islet cells but not the adjacent exocrine cells.
The current studies lead to a model in which menin normally regulates the levels of p18
Ink4c and p27 Kip1 to repress CDK2 activity and limit islet cell proliferation. Accordingly, mutation of Men1 results in increased islet cell proliferation. Men1 excision quickly results in increased pancreatic islet proliferation, which may help to initiate development of islet hyperplasia. The enhanced proliferation of pancreatic islet cells, perhaps in combination with decreased apoptosis and genome stability, may further accelerate the rate of secondary genetic and/or epigenetic alterations, leading to the development of insulinomas. However, the current studies do not rule out that additional menin-related regulators, such as JunD (3), cyclin D1 (32) , and activator of S-phase kinase (5), are also involved in the regulation of islet cell proliferation. In conclusion, these studies show that menin plays an essential role in the tissuespecific suppression of pancreatic islet cell proliferation and in inhibition of the G 0 /G 1 -S transition. Furthermore, these findings suggest the possibility that targeting the CDK2 axis may prove useful in treating MEN1 islet tumors, and set the stage to further investigate precisely how menin specifically up-regulates the transcription of the p18
Ink4c and p27 Kip1 genes.
